Effect of High-dose Vitamin A Supplementation in Children With Sickle Cell Disease: A Randomized, Double-blind,

Jefferson N Brownell1,2, Joan I Schall1, Carolyn R Mcanlis1

  • 1Division of Gastroenterology, Hepatology, and Nutrition.

Insights

High-dose vitamin A supplementation did not improve vitamin A status in children with hemoglobin-SS disease (HbSS). However, it led to improvements in fetal hemoglobin and erythrocyte indices.

Area of Science:

  • Pediatric Hematology
  • Nutritional Science
  • Clinical Research

Background:

  • Suboptimal vitamin A status is linked to adverse outcomes in children with hemoglobin-SS disease (HbSS).
  • Standard Recommended Daily Allowance (RDA) of retinol is ineffective for improving vitamin A status in this population.

Purpose of the Study:

  • To compare vitamin A and nutritional status in children with HbSS versus healthy children.
  • To explore the impact of high-dose vitamin A supplementation on serum vitamin A status and other health parameters in children with HbSS.

Main Methods:

  • A single-center, randomized, blinded, dose-finding pilot study.
  • 22 children with HbSS were randomized to receive 3000 or 6000 IU/d of oral retinol for 8 weeks.
  • Mixed-effects linear regression was used to analyze associations between vitamin A dose, serum retinol, and outcomes.

Main Results:

  • Children with HbSS exhibited suboptimal serum retinol, growth, and nutritional status at baseline.
  • Vitamin A supplementation did not alter serum vitamin A levels.
  • Significant improvements were observed in fetal hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration.

Conclusions:

  • High-dose vitamin A supplementation does not improve vitamin A status in children with HbSS.
  • Supplementation showed positive effects on hematologic parameters, including fetal hemoglobin and erythrocyte indices.
  • Mild improvements in growth and muscle function were noted, independent of hydroxyurea treatment.